Skip to main content
PREVIEW · SAMPLE DATA
This is the SER dossier with made-up numbers. Sign up free to see live prices, insider trades, 13F flows and fundamentals for SER.

SER

Serina Therapeutics, Inc.
Healthcare · Biotechnology
$246.47 sample
-0.81 (-0.33%) 1D
☆ Watch
Market cap
$750.0B
Price as of
2026-10-29
Latest filing
8-K · 2026-10-07
Alerts
8
Price$246.47 +10.01% 3M daily closessample
247.28206.08
2026-08-032026-08-252026-09-162026-10-072026-10-29
purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first
  • Oct 22INSInsider sell: Chief Executive Officer
  • Oct 13INSInsider sell: EVP, Operations
  • Oct 07SEC10-Q filed
  • Oct 02INSInsider buy: General Counsel
  • Sep 25INSInsider sell: 10% owner
  • Sep 21INSInsider sell: Chief Executive Officer
  • Sep 10SEC10-Q filed
  • Sep 04INSInsider buy: Chief Executive Officer
Sign up to see the real SER record →

Company facts

SEC EDGAR registration
Name
Serina Therapeutics, Inc.
Sector
Healthcare
Industry
Biotechnology
Smart-money score
+33sample, -100 to +100
Reporting currency
USD

Who is positioning in SER

sample
Insiders
18 insider transactions over 90 days, net selling, $832.6M
Congress
No member trades over 90 days
Institutions · 13F
39 funds hold $10.8B
Activists · 13D/G
No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end
Revenue$32.8B +12.8% y/y
Q4 2024Q3 2026
Inventory$20.4B +14.8% y/y
Q4 2024Q3 2026
Accounts receivable$15.5B +13.6% y/y
Q4 2024Q3 2026
Total debt$41.2B +18.8% y/y
Q4 2024Q3 2026

Peers

sample
Sample peer A
$383.9B -9.1% 3M
Sample peer B
$476.0B -12.7% 3M
Sample peer C
$686.0B +11.7% 3M
Sample peer D
$669.9B -5.5% 3M
Sample peer E
$695.2B -0.6% 3M
Preview. Company name, sector and industry are from SEC EDGAR; every price, flow, filing count and fundamental on this page is sample data generated for the preview and is not SER's real figure. Nothing here is investment advice.